Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$0.17 - $0.34 $25,065 - $50,130
147,442 Added 241.07%
208,603 $40,000
Q1 2022

May 16, 2022

SELL
$0.25 - $0.43 $7,320 - $12,591
-29,283 Reduced 32.38%
61,161 $19,000
Q4 2021

Feb 14, 2022

SELL
$0.34 - $1.0 $38,282 - $112,596
-112,596 Reduced 55.46%
90,444 $32,000
Q3 2021

Nov 15, 2021

BUY
$0.96 - $1.62 $57,342 - $96,765
59,732 Added 41.68%
203,040 $195,000
Q2 2021

Aug 16, 2021

BUY
$1.09 - $1.49 $156,205 - $213,528
143,308 New
143,308 $201,000
Q1 2021

May 17, 2021

SELL
$1.26 - $2.02 $46,773 - $74,986
-37,122 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$0.9 - $1.54 $180,763 - $309,305
-200,848 Reduced 84.4%
37,122 $50,000
Q3 2020

Nov 16, 2020

SELL
$0.87 - $2.08 $108,007 - $258,223
-124,146 Reduced 34.28%
237,970 $226,000
Q2 2020

Aug 14, 2020

BUY
$1.08 - $4.0 $182,922 - $677,492
169,373 Added 87.88%
362,116 $561,000
Q1 2020

May 14, 2020

SELL
$1.01 - $2.74 $17,983 - $48,785
-17,805 Reduced 8.46%
192,743 $220,000
Q4 2019

Feb 14, 2020

SELL
$1.2 - $2.34 $82,688 - $161,242
-68,907 Reduced 24.66%
210,548 $337,000
Q3 2019

Nov 14, 2019

SELL
$1.3 - $1.76 $145,685 - $197,236
-112,066 Reduced 28.62%
279,455 $363,000
Q2 2019

Aug 15, 2019

SELL
$1.63 - $3.3 $284,679 - $576,345
-174,650 Reduced 30.85%
391,521 $673,000
Q2 2019

Aug 14, 2019

BUY
$1.63 - $3.3 $922,858 - $1.87 Million
566,171 New
566,171 $47.5 Million
Q2 2018

Aug 14, 2018

SELL
$4.44 - $10.4 $1.28 Million - $3.01 Million
-288,990 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$4.85 - $6.92 $1.28 Million - $1.82 Million
263,681 Added 1041.85%
288,990 $1.5 Million
Q4 2017

Feb 14, 2018

BUY
$4.91 - $5.5 $124,267 - $139,199
25,309
25,309 $126,000

Others Institutions Holding CWBR

# of Institutions
1
Shares Held
1.14K
Call Options Held
0
Put Options Held
0

About CohBar, Inc.


  • Ticker CWBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,906,940
  • Market Cap $1.45M
  • Description
  • CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...
More about CWBR
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.